LEADER 03553nam  22005535  450 
001 9910300223803321
005 20200706053300.0
010   $a3-319-17332-4
024 7 $a10.1007/978-3-319-17332-0
035   $a(CKB)3710000000422035
035   $a(EBL)2095814
035   $a(SSID)ssj0001524748
035   $a(PQKBManifestationID)11918832
035   $a(PQKBTitleCode)TC0001524748
035   $a(PQKBWorkID)11484881
035   $a(PQKB)11195729
035   $a(DE-He213)978-3-319-17332-0
035   $a(MiAaPQ)EBC2095814
035   $a(PPN)186397909
035   $a(EXLCZ)993710000000422035
100   $a20150602d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aPharmacological Treatment of Chronic Stable Angina Pectoris /$fedited by Pablo Avanzas, Juan Carlos Kaski
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (289 p.)
225 1 $aCurrent Cardiovascular Therapy
300   $aDescription based upon print version of record.
311   $a3-319-17331-6 
320   $aIncludes bibliographical references and index.
327   $aMechanisms of angina -- An overview of treatment and guidelines ? ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
330   $aThis book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
410  0$aCurrent Cardiovascular Therapy
606   $aCardiology
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
615  0$aCardiology.
615 14$aCardiology.
676   $a610
676   $a616.12
702   $aAvanzas$b Pablo$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aKaski$b Juan Carlos$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300223803321
996   $aPharmacological Treatment of Chronic Stable Angina Pectoris$91831056
997   $aUNINA